Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-29Clinical Trial Update: Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)
The BURGER With BACON trial (NCT06283238) evaluating biobanking of upper gastrointestinal tumors to evaluate response has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-01-21Clinical Trial Update: Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b [Phase 2]
A Phase 2 trial evaluating bemarituzumab in combination with FLOT chemotherapy for perioperative treatment of FGFR2b-overexpressing gastric/…
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]
A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of AB-201 for HER2-positive solid tumors has been withdrawn, with the study status updated to withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-09Clinical Trial Update: Study of OB-002 in Patients With Refractory Metastatic Cancer [Phase 1]
Phase 1 study of OB-002 in various metastatic cancers has been withdrawn from clinical trials.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-03Clinical Trial Update: Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-18Clinical Trial Update: TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors [Phase 1, Phase 2]
Tarus Therapeutics has withdrawn its TT-4 single-agent trial in advanced solid tumors across Phase 1 and Phase 2. The listed conditions incl…
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach [Phase 2]
A Phase 2 trial evaluating apatinib with oxaliplatin and S-1 for advanced gastric cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-07Clinical Trial Update: Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers [Phase 1]
A Phase 1 neoadjuvant therapy trial for gastroesophageal junction and gastric cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-24Clinical Trial Update: Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 [Phase 1]
The Phase 1 trial of AB-201 for breast cancer, gastric cancer, and gastroesophageal junction adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-03Clinical Trial Update: Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer [Phase 3]
A Phase 3 trial comparing adjuvant S-1 plus oxaliplatin to S-1 alone in locally advanced gastric cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2024-11-06Clinical Trial Update: Perioperative Chemotherapy in Gastric Cancer [Phase 2]
A Phase 2 trial evaluating perioperative chemotherapy for gastric cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2024-10-26Clinical Trial Update: An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study [NA]
A clinical trial evaluating an exercise and nutrition monitoring intervention for strengthening patients with gastric or pancreatic cancer u…
-
CLINICAL_TRIALS withdrawal · 2023-12-04Clinical Trial Update: Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections [Phase 3]
Phase 3 trial investigating viscosity of submucosal gel injections for endoscopic mucosal resection was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-07-19Clinical Trial Update: A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients [Phase 4]
A Phase 4 clinical trial evaluating indocyanine green lymphangiography to improve lymphadenectomy in gastric cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-12-16Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension [Phase 3]
A Phase 3 trial (MK-3475-859/KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenoca…
-
CLINICAL_TRIALS withdrawal · 2019-12-30Clinical Trial Update: Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer [Phase 3]
Phase 3 trial comparing XELOX vs capecitabine alone in elderly patients with advanced gastric cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-05-08Clinical Trial Update: Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. [Phase 3]
Phase 3 clinical trial comparing S-1 for 6 months to 1 year as adjuvant chemotherapy after D2 gastrectomy in gastric cancer (stages II, IIIA…
-
CLINICAL_TRIALS withdrawal · 2018-03-26Clinical Trial Update: Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 trial evaluating nimotuzumab plus irinotecan as second-line therapy for advanced or recurrent gastric and gastroesophageal junctio…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Gastric In Vivo Study [Phase 1]
A Phase 1 gastric cancer trial (Gastric In Vivo Study) has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-03-14Clinical Trial Update: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment [Phase 2]
A Phase 2 trial evaluating Afatinib in combination with weekly Paclitaxel as second-line therapy for HER-2 positive gastric and gastroesopha…
-
CLINICAL_TRIALS withdrawal · 2017-02-02Clinical Trial Update: Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens
A clinical trial comparing nursing and pharmacy care between capecitabine and 5-fluorouracil regimens for gastric cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-26Clinical Trial Update: Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
A clinical trial assessing the EnLight and LightPath imaging systems for gastrointestinal tumor surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers [Phase 2]
Phase 2 trial of personalized therapy for esophagogastric cancer using thymidylate synthase genetic markers has been withdrawn.